Symbol="CERS"
AssetType="Common Stock"
Name="Cerus Corporation"
Description="Cerus Corporation, a biomedical products company, is focused on developing and commercializing the INTERCEPT Blood System to improve blood safety. The company is headquartered in Concord, California."
CIK="1020214"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="SURGICAL & MEDICAL INSTRUMENTS & APPARATUS"
Address="1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="323639000"
EBITDA="-38424000"
PERatio="None"
PEGRatio="0"
BookValue="0.281"
DividendPerShare="0"
DividendYield="0"
EPS="-0.29"
RevenuePerShareTTM="0.86"
ProfitMargin="-0.332"
OperatingMarginTTM="-0.268"
ReturnOnAssetsTTM="-0.124"
ReturnOnEquityTTM="-0.796"
RevenueTTM="153432000"
GrossProfitTTM="87094000"
DilutedEPSTTM="-0.29"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.052"
AnalystTargetPrice="5.75"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="4.742"
PriceToBookRatio="9.56"
EVToRevenue="4.324"
EVToEBITDA="-23.21"
Beta="1.056"
num_52WeekHigh="4.35"
num_52WeekLow="1.66"
num_50DayMovingAverage="2.362"
num_200DayMovingAverage="2.843"
SharesOutstanding="180552000"
DividendDate="None"
ExDividendDate="None"
symbol="CERS"
open="1.69"
high="1.79"
low="1.69"
price="1.79"
volume="633177.00"
latest_trading_day="2023-08-25"
previous_close="1.69"
change="0.10"
change_percent="5.9172%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="79"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="21"
Volume_recent_avg="1211861"
Change_recent_avg="-0.01"
Delta_recent_avg="0.14"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.76"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="21"
Aroon_momentum_negative="79"
image_negative_thumbnail_id_1="122"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0054.jpeg"
image_negative_thumbnail_id_2="518"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0087.jpeg"
image_neutral_thumbnail_id_1="432"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_neutral_thumbnail_id_2="539"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0060.jpeg"
image_positive_thumbnail_id_1="644"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0064.jpeg"
image_positive_thumbnail_id_2="699"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0009.jpeg"
image_professor_thumbnail_id_1="1201"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
image_professor_thumbnail_id_2="1195"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
